XML 20 R7.htm IDEA: XBRL DOCUMENT v3.21.2
CONDENSED CONSOLIDATED STATEMENTS OF REDEEMABLE CONVERTIBLE PREFERRED STOCK AND STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Class A and Class B Common Stock
Additional Paid-In Capital
Accumulated Other Comprehensive Loss
Retained Earnings/Accumulated Deficit
Beginning balance (in shares) at Mar. 31, 2020 76,287,000        
Beginning balance at Mar. 31, 2020 $ 81,458        
Ending balance (in shares) at Sep. 30, 2020 76,287,000        
Ending balance at Sep. 30, 2020 $ 81,458        
Beginning balance (in shares) at Mar. 31, 2020   68,566,000      
Beginning balance at Mar. 31, 2020 1,136 $ 68 $ 14,954 $ 0 $ (13,886)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 2,256   2,256    
Exercise of stock options (in shares)   7,912,000      
Exercise of stock options 3,274 $ 7 3,267    
Issuance of common stock in exchange for services (in shares)   22,000      
Issuance of common stock in exchange for services 34   34    
Vesting of common stock warrants 67   67    
Other comprehensive loss 0        
Issuance of common stock in connection with an acquisition (in shares)   690,000      
Issuance of common stock in connection with an acquisition 1,062 $ 1 1,061    
Net income 11,496       11,496
Ending balance (in shares) at Sep. 30, 2020   77,190,000      
Ending balance at Sep. 30, 2020 $ 19,325 $ 76 21,639 0 (2,390)
Beginning balance (in shares) at Jun. 30, 2020 76,287,000        
Beginning balance at Jun. 30, 2020 $ 81,458        
Ending balance (in shares) at Sep. 30, 2020 76,287,000        
Ending balance at Sep. 30, 2020 $ 81,458        
Beginning balance (in shares) at Jun. 30, 2020   69,760,000      
Beginning balance at Jun. 30, 2020 4,960 $ 69 17,318 0 (12,427)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 1,232   1,232    
Exercise of stock options (in shares)   7,430,000      
Exercise of stock options 3,052 $ 7 3,045    
Vesting of common stock warrants 44   44    
Other comprehensive loss 0        
Net income 10,037       10,037
Ending balance (in shares) at Sep. 30, 2020   77,190,000      
Ending balance at Sep. 30, 2020 $ 19,325 $ 76 21,639 0 (2,390)
Beginning balance (in shares) at Mar. 31, 2021 76,286,618        
Beginning balance at Mar. 31, 2021 $ 81,458        
Increase (Decrease) in Temporary Equity [Roll Forward]          
Conversion of redeemable convertible preferred stock upon initial public offering (in shares) (76,287,000)        
Conversion of redeemable convertible preferred stock upon initial public offering $ (81,458)        
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Beginning balance (in shares) at Mar. 31, 2021   82,910,000      
Beginning balance at Mar. 31, 2021 66,743 $ 83 30,357 (21) 36,324
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation $ 11,916   11,916    
Exercise of stock options (in shares) 5,446,000 5,446,000      
Exercise of stock options $ 5,065 $ 6 5,059    
Vesting of restricted stock units (in shares)   3,000      
Tax withholding on shares under stock-based compensation awards (56)   (56)    
Repurchase and retirement of common stock (in shares)   (181,000)      
Repurchase and retirement of common stock (2,698)   (2,698)    
Vesting of common stock warrants 24   24    
Other comprehensive loss (754)     (754)  
Conversion of redeemable convertible preferred stock upon initial public offering (in shares)   76,287,000      
Conversion of redeemable convertible preferred stock upon initial public offering 81,458 $ 76 81,382    
Issuance of common stock upon initial public offering, net of underwriting discounts and offering costs (in shares)   22,506,000      
Issuance of common stock upon initial public offering, net of underwriting discounts and commissions and deferred offering costs 548,452 $ 22 548,430    
Net income 62,410       62,410
Ending balance (in shares) at Sep. 30, 2021   186,971,000      
Ending balance at Sep. 30, 2021 $ 772,560 $ 187 674,414 (775) 98,734
Beginning balance (in shares) at Jun. 30, 2021 0        
Beginning balance at Jun. 30, 2021 $ 0        
Ending balance (in shares) at Sep. 30, 2021 0        
Ending balance at Sep. 30, 2021 $ 0        
Beginning balance (in shares) at Jun. 30, 2021   185,207,000      
Beginning balance at Jun. 30, 2021 728,452 $ 185 665,690 (69) 62,646
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Stock-based compensation 6,740   6,740    
Exercise of stock options (in shares)   1,761,000      
Exercise of stock options 2,030 $ 2 2,028    
Vesting of restricted stock units (in shares)   3,000      
Tax withholding on shares under stock-based compensation awards (56)   (56)    
Vesting of common stock warrants 12   12    
Other comprehensive loss (706)     (706)  
Net income 36,088       36,088
Ending balance (in shares) at Sep. 30, 2021   186,971,000      
Ending balance at Sep. 30, 2021 $ 772,560 $ 187 $ 674,414 $ (775) $ 98,734